Location · Burlington, VT
Clinical trials in Burlington, VT
20 recruiting studies have a site in Burlington, and 7 of them accept healthy volunteers.
20 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingHealthy volunteers
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Ecotera Health LLC
- Location
- Burlington, VT + 50 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Location
- Burlington, VT + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Sanofi
- Location
- Burlington, VT + 31 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
Kiniksa Pharmaceuticals International, plc
- Location
- Burlington, VT + 29 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingPhase 3
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
AstraZeneca
- Location
- Burlington, VT + 70 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 2
An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
Zomagen Biosciences Ltd.
- Location
- Burlington, VT + 14 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Eli Lilly and Company
- Location
- Burlington, VT + 10 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Hoffmann-La Roche
- Location
- Burlington, VT + 52 other US sites
- Eligibility basics
- Ages 50–85
- Recruiting
ELEVATE-HFpEF Clinical Study
Medtronic Cardiac Rhythm and Heart Failure
- Location
- Burlington, VT + 25 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 3
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Novartis Pharmaceuticals
- Location
- Burlington, VT + 39 other US sites
- Eligibility basics
- Ages 21–70
- Recruiting
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Medtronic Cardiovascular
- Location
- Burlington, VT + 68 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
Cardiol Therapeutics Inc.
- Location
- Burlington, VT + 20 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
BlueRock Therapeutics
- Location
- Burlington, VT + 33 other US sites
- Eligibility basics
- Ages 45–75
- Recruiting
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Endotronix, Inc.
- Location
- Burlington, VT + 43 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Deep Functional Phenotyping of the ALA Lung Health Cohort
Johns Hopkins University
- Location
- Burlington, VT + 11 other US sites
- Eligibility basics
- Ages 25–35
- RecruitingHealthy volunteers
Fatty Acid Modulation of Brain Function in Older Adults
University of Vermont
- Location
- Burlington, VT
- Eligibility basics
- Ages 65–75
- RecruitingHealthy volunteersPhase 2
Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes
University of Vermont
- Location
- Burlington, VT + 1 other US site
- Eligibility basics
- Ages 21+
- RecruitingHealthy volunteers
Improving Neurodevelopmental ouTcomes After Prenatal Cannabinoid in uTero Exposure
IDeA States Pediatric Clinical Trials Network
- Location
- Burlington, VT + 2 other US sites
- Eligibility basics
- Up to age 0 mo
- RecruitingHealthy volunteers
PRESERVE & CONNECT: Impact Study of the BPC
University of Vermont
- Location
- Burlington, VT + 1 other US site
- Eligibility basics
- Any age listed
- RecruitingHealthy volunteers
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
CHDI Foundation, Inc.
- Location
- Burlington, VT + 51 other US sites
- Eligibility basics
- Ages 18+